Peter A. Winstanley
Department of Pharmacology and Therapeutics
University of Liverpool
L69 3GE
UK
Name/email consistency: high
- Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy. Winstanley, P., Ward, S., Snow, R., Breckenridge, A. Clin. Microbiol. Rev. (2004)
- The contribution of clinical pharmacology to antimalarial drug discovery and development. Winstanley, P. Br. J. Clin. Pharmacol (2003)
- Clinical status and implications of antimalarial drug resistance. Winstanley, P.A., Ward, S.A., Snow, R.W. Microbes Infect. (2002)
- Coping with malaria in the face of resistance. Winstanley, P. Int. J. Infect. Dis. (2002)
- Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria. Winstanley, P. Trop. Med. Int. Health (2001)
- Modern chemotherapeutic options for malaria. Winstanley, P. Lancet. Infect. Dis (2001)
- Chemotherapy for falciparum malaria: the armoury, the problems and the prospects. Winstanley, P.A. Parasitol. Today (Regul. Ed.) (2000)
- New prospects for the treatment of malaria. Winstanley, P. Expert. Opin. Investig. Drugs (1997)
- Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range. Winstanley, P., Watkins, W., Muhia, D., Szwandt, S., Amukoye, E., Marsh, K. Trans. R. Soc. Trop. Med. Hyg. (1997)